APOL1 inhibitor
Search documents
Maze Therapeutics (NasdaqGM:MAZE) Update / briefing Transcript
2026-03-25 13:02
Maze Therapeutics (NasdaqGM:MAZE) Update / briefing March 25, 2026 08:00 AM ET Company ParticipantsDebjit Chattopadhyay - Senior Managing DirectorHarold Bernstein - President of Research and Development and Chief Medical OfficerJason Coloma - CEOJulian Harrison - Managing DirectorLaura Chico - Managing DirectorMartin Auster - Managing DirectorSadia Rahman - VP of Biopharma Equity ResearchConference Call ParticipantsAnanda Ghosh - VP and Research AnalystAnupam Rama - Executive Director and Biotechnology Equi ...